BCP was demonstrated to alleviate colitis by increasing glutathione peroxidase 4 (GPX4) expression, GPX activity and GSH content, reducing the levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) in the colon of UC mice. This evidence concerns the gene OPN1SW and colitis.